Evidence map›Paper›PMID 25784557›Full record

ArticleThe Journal of biological chemistry2015

The c-Cbl ubiquitin ligase regulates nuclear β-catenin and angiogenesis by its tyrosine phosphorylation mediated through the Wnt signaling pathway.

Sowmya Shivanna, Itrat Harrold, Moshe Shashar, Rosanna Meyer, Chrystelle Kiang, Jean Francis, Qing Zhao, Hui Feng, Elazer R Edelman, Nader Rahimi and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. New insights into the role of ubiquitination in angiogenesis (Review).International journal of molecular medicine · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Zebrafish Cancer Predisposition Models.Frontiers in cell and developmental biology · 2021
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Sowmya ShivannaFrom the Renal Section, Department of Medicine.
Itrat HarroldSection of Hematology and Medical Oncology, Departments of Pharmacology and Medicine, and.
Moshe ShasharFrom the Renal Section, Department of Medicine.
Rosanna Meyerthe Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts 02118.
Chrystelle Kiangthe Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, and the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Jean FrancisFrom the Renal Section, Department of Medicine.
Qing Zhaothe Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts 02118.
Hui FengSection of Hematology and Medical Oncology, Departments of Pharmacology and Medicine, and.
Elazer R Edelmanthe Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, and the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Nader Rahimithe Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts 02118.
Vipul C ChitaliaFrom the Renal Section, Department of Medicine, vichital@bu.edu.
Boston University · USBrigham and Women's Hospital · US

Funding

Vascular Drug Delivery - Supplement for EquipmentR01GM049039 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI EDELMAN, ELAZER R · 1994 to 2019
$8.9M
RESEARCH TRAINING IN BLOOD DISEASES AND RESOURCEST32HL007501 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LERNER, ADAM, STEINBERG, MARTIN H. · 1985 to 2018
$5.4M
Role of c-Cbl in Colon cancerR01CA175382 · NCI · BOSTON MEDICAL CENTER · PI CHITALIA, VIPUL C · 2014 to 2018
$1.8M
Role of Protein Ubiquitination in AngiogenesisR01EY017955 · NEI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAHIMI, NADER · 2008 to 2010
$1.2M
"Oncorequisite" Genes in MYC-mediated TransformationR00CA134743 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FENG, HUI · 2012 to 2014
$712k
Overcoming the resistance to anti-angiogenesis therapyR21CA191970 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAHIMI, NADER · 2015 to 2016
$392k
NCI NIH HHS CA191970NCI NIH HHS R00 CA134743NCI NIH HHS R00CA134743NCI NIH HHS R01 CA175382NCI NIH HHS R21 CA191970NEI NIH HHS R01 EY017955NEI NIH HHS R01EY017955NHLBI NIH HHS T32 HL007501NIGMS NIH HHS R01 GM049039NIGMS NIH HHS R01 GM49039
6 · The paper itself

Abstract

Wnt signaling plays important roles in both the tumor-induced angiogenesis and tumorigenesis through the transcriptionally active nuclear β-catenin. Recently, c-Cbl was identified as a unique E3 ubiquitin ligase targeting the active nuclear β-catenin. However, little is known about the molecular mechanisms by which c-Cbl regulates ubiquitination and degradation of active β-catenin. Here, we demonstrate that Wnt activation promotes the phosphorylation of c-Cbl at tyrosine 731(Tyr-731), which increases c-Cbl dimerization and binding to β-catenin. Tyr-731 phosphorylation and dimerization mediate c-Cbl nuclear translocation and lead to the degradation of nuclearly active β-catenin in the Wnt-on phase. c-Cbl activation also inhibits expression of the pro-angiogenic Wnt targets, IL-8 and VEGF. Phospho-Tyr-731-inactive mutant c-Cbl (Y731F) enhances and phosphomimetic mutant c-Cbl (Y731E) suppresses angiogenesis in zebrafish. Taken together, we have identified a novel mechanism for the regulation of active nuclear β-catenin by c-Cbl and its critical role in angiogenesis. This mechanism can be further explored to modulate both the pathological angiogenesis and the tumorigenesis.

Indexed as

Amino Acid SubstitutionAnimalsbeta CateninCell NucleusHumansHuman Umbilical Vein Endothelial CellsMutation, MissenseNeovascularization, PhysiologicPhosphorylationProtein MultimerizationProteolysisProto-Oncogene Proteins c-cblWnt Signaling PathwayZebrafishZebrafish Proteinsbeta CateninCBL protein, humanProto-Oncogene Proteins c-cblZebrafish ProteinsAngiogenesisCblE3 Ubiquitin LigaseTumor Cell BiologyTumorigenesisTumorsWnt SignalingZebrafishβ-Catenin

Identifiers

PMID25784557
PMCPMC4432275
OpenAlexW338487925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.